Balyasny Asset Management L.P.

Position in SABS — SAB Biotherapeutics, Inc.

CIK 1218710 Chicago, IL

Position in SABS

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$14,665,712

+$263,231 QoQ

Shares Held

3,760,439

0.0% QoQ

Ownership

4.13%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

of 86 holders

Holding Since

Dec 2021

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Balyasny Asset Management L.P. holds $2,350,910,046 across 177 Biotechnology names. SABS ranks #49 (0.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	APGE	Apogee Therapeutics, Inc.	1,665,102	$221,008,988
2	INSM	INSMED Inc	1,326,430	$141,423,966
3	BBIO	BridgeBio Pharma, Inc.	1,230,052	$91,614,272
4	ABVX	Abivax S.A.	603,840	$80,467,718
5	VRTX	Vertex Pharmaceuticals Inc / Ma	145,005	$72,028,333
6	TNGX	Tango Therapeutics, Inc.	2,016,379	$63,032,007
7	CYTK	Cytokinetics Inc	711,676	$60,627,678
8	BMRN	Biomarin Pharmaceutical Inc	1,054,613	$60,344,955

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$28,179,212	7,225,439	—	Shares	Sole	2026-08-14
2026-06-30	$14,665,712	3,760,439	0.0%	Shares	Sole	2026-08-14
2026-03-31	$14,402,481	3,760,439	+690.9%	Shares	Sole	2026-05-15
2025-12-31	$1,778,141	475,439	—	Shares	Sole	2026-02-17
2023-03-31 SABSW	—	281,107	0.0%	Shares	Sole	2023-05-15
2022-12-31 SABSW	—	281,107	0.0%	Shares	Sole	2023-02-14
2022-09-30 SABSW	—	281,107	0.0%	Shares	Sole	2022-11-15
2022-06-30 SABSW	—	281,107	0.0%	Shares	Sole	2022-08-15
2022-03-31 SABSW	—	281,107	0.0%	Shares	Sole	2022-05-16
2021-12-31 SABSW	—	281,107	—	Shares	Sole	2022-02-14
No filing history on record for this holder in this stock.